$ARTL currently untouched at $4.70 with news this morning; Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and

$ARTL currently untouched at $4.70 with news this morning; Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings. Market is shifting away from the morning movers an…